Search

everythinglearnresearchcommunity

for

Search:↓

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

ATP helps prevent skin damage from vandetanib by reducing stress.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Use trichoscopy to diagnose hair loss; treat with minoxidil, finasteride, or dutasteride; consider platelet-rich plasma and spironolactone.

Belimumab effectively controls SLE disease activity and reduces steroid use.

People with psoriasis and depression have lower BDNF levels, which could help measure depression in those with psoriasis.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Topical treatments for hair loss can be effective but need careful safety evaluation.

MSC-protein helps regenerate gum tissue and bone.

Histone modification is key in treating chronic inflammatory skin diseases.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Chemotherapy often causes hair loss in cancer patients, affecting their mental health, but scalp cooling can help prevent it.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Silk sericin dressing with collagen heals wounds faster and improves scar quality better than Bactigras.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Some drugs can cause serious side effects like heart issues and nervous system problems, but certain drugs for Parkinson's and overactive bladder may be safer, though they still have some common side effects.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.